Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial

Background: Quercetin, a natural polyphenol with demonstrated broad-spectrum antiviral, anti-inflammatory, and antioxidant properties, has been proposed as an adjuvant for early-stage coronavirus disease 2019 (COVID-19) infection.Objective: To explore the possible therapeutic effect of quercetin in...

詳細記述

書誌詳細

主要な著者:	Francesco Di Pierro, Amjad Khan, Somia Iqtadar, Sami Ullah Mumtaz, Muhammad Nabeel Akbar Chaudhry, Alexander Bertuccioli, Giuseppe Derosa, Pamela Maffioli, Stefano Togni, Antonella Riva, Pietro Allegrini, Martino Recchia, Nicola Zerbinati
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2023-01-01
シリーズ:	Frontiers in Pharmacology
主題:	Quercetin COVID-19 SARS-CoV-2 Phytosome® Natural Polyphenols 3CL protease inhibition
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1096853/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!